Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04259697
Other study ID # Ece Korkmaz
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 15, 2018
Est. completion date May 15, 2020

Study information

Verified date February 2020
Source Dokuz Eylul University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim is to compare the effects of clinical pilates and whole body vibration exercises in postmenopausal osteoporotic women on strength, flexibility, balance, bone turnover markers and quality of life.


Description:

The aim of this study is to compare the effects of clinical pilates and whole body vibration exercises in postmenopausal osteoporotic women in terms of strength, flexibility, balance, bone turnover markers and quality of life. Thirty-four women who are diagnosed with postmenopausal osteoporosis will be recruited into the study. Participants will be divided into two groups: (1) clinical pilates group, (2) vibration exercises group. Exercise programs will be performed two times per week for twelve weeks. The strength of the extensor muscles of the hip, knee, back, elbow will be measured with a hand-held dynamometer. Flexibility will be assessed measuring the fingertip-to-floor distance in flexion and lateral bending. The balance performance will be assessed using the timed up and go test, Tetrax fall index and the maximum hold time on unipedal stance and on tandem stance. The short form-12 questionnaire will be used to assess the quality of life. Also, bone turnover markers will be measured. All assessments will be performed before and after exercise programs.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 34
Est. completion date May 15, 2020
Est. primary completion date April 15, 2020
Accepts healthy volunteers No
Gender Female
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- Being in the postmenopausal period

- Having body mass index equal to or greater than 18,5 kg/m²

- A lack of regular exercise

- Having been diagnosed with osteoporosis

- Having the ability to walk independently

Exclusion Criteria:

- Having a cardiopulmonary problem that may prevent participating in exercise programs

- Having kidney stones

- Being diagnosed with diabetes

- Presence of epilepsy

- Having cardiological problems such as arrhythmia, using a pacemaker, hypertension

- Having neurological disorders such as Parkinson, stroke, multiple sclerosis, neuropathy

- Having surgery in the last 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Clinical pilates
Clinical pilates exercises will be performed progressively. The duration of each exercise session will be an average of 40 minutes initially and then will be increased to 60 minutes as the program progress.
Whole body vibration
Whole body vibration exercises will be performed using the Power Plate pro5 AIRdaptive machine.The duration of each exercise session will be an average of 20 minutes initially and then will be increased to 30 minutes as the program progress.

Locations

Country Name City State
Turkey Dokuz Eylul University, School of Physical Therapy and Rehabilitation Izmir

Sponsors (1)

Lead Sponsor Collaborator
Dokuz Eylul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Strength The strength of the extensor muscles of the hip, knee, back, elbow will be assessed with a hand-held dynamometer. Change in strength measures from baseline to twelve weeks
Primary Flexibility Flexibility wil be assessed measuring the fingertip-to-floor distance in flexion and lateral bending. Change in flexibility measures from baseline to twelve weeks
Primary Timed up and go test Timed up and go test will be used to assess dynamic balance. Change in Timed up and go test from baseline to twelve weeks
Primary The maximum hold time on unipedal stance and on tandem stance. The maximum hold time will be calculated to assess static balance. Change in the maximum hold time from baseline to twelve weeks
Primary Tetrax fall index Tetrax fall index will be calculated to determine fall risk. Change in Tetrax fall index from baseline to twelve weeks
Primary The short form-12 questionnaire The short form-12 questionnaire will be used to assess quality of life. The total score can range from 0 to 100. Lower SF-12 score indicated poorer physical and mental health. Change in quality of life measure from baseline to twelve weeks
Primary Dual-energy X-ray absorptiometry of hip and lumbar spine Dual-energy X-ray absorptiometry of hip and lumbar spine will be measured to assess bone density. Change in the Dual-energy X-ray absorptiometry of hip and lumbar spine from baseline to twelve weeks
Primary Plasma sclerostin concentration Plasma sclerostin concentration will be measured to assess the process of bone resorption and formation. Change in plasma sclerostin concentration from baseline to twelve weeks
Primary Urinary deoxypyridinoline Urinary deoxypyridinoline level will be measured to assess bone resorption. Change in urinary deoxypyridinoline level from baseline to twelve weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06287502 - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis N/A
Completed NCT03822078 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women Phase 1
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Completed NCT04736693 - Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Not yet recruiting NCT06431867 - Primary Care Management of Osteoporosis in Older Women
Completed NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study
Recruiting NCT02635022 - Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Active, not recruiting NCT02617303 - Prevention of Falls and Its Consequences in Elderly People N/A
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Completed NCT03420716 - Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women N/A
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Completed NCT02559648 - Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis Phase 2
Completed NCT02003716 - DeFRA Questionnaire as an Anamnestic Form N/A
Not yet recruiting NCT01854086 - Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday N/A
Unknown status NCT01913834 - Nasally and sc Administered Teriparatide in Healthy Volunteers Phase 1
Completed NCT01401556 - C-STOP Fracture Trial N/A
Completed NCT01757340 - Calorie Restriction With Leucine Supplementation N/A